Sepsis 2018

Sepsis 2018: New Successes, New Challenges

Abstract submission is now closed!

A joint meeting with the Thai Society of Critical Care Medicine (TSCCM)

Please visit the TSCCM Conference site here:  Thai Society of Critical Care Medicine

Sepsis 2018 is the ISF’s 12th annual Symposium.  Sepsis 2018 will be held in Bangkok Thailand.  We are expecting an audience of 300 delegates from around the world for Sepsis 2018.  Past symposia have attracted delegates from more than 40 countries.  The official language will be English.

Sepsis 2018 will feature presentations by international experts, who will cover the most important topics of sepsis, spanning the spectrum from cutting edge basic science research to clinical aspects and trials.

Sepsis 2018 is an excellent opportunity to become up-to-date on everything that currently is going on in the field of sepsis!  In addition, there will be ample possibilities to present own scientific work and to informally interact with ISF council members during poster sessions.


Click Here to download Sepsis 2018 Bangkok 2nd Announcement



Sponsored by the International Sepsis Forum.

International Sepsis Forum Logo

The Sepsis Annual Symposium

The Sepsis Annual Symposium is a unique meeting at which world experts address the diagnosis, epidemiology, science and clinical treatment of sepsis.  The faculty features international thought leaders from the fields of critical care, infectious diseases, internal medicine and surgery, who collectively have extensive expertise in the clinical care of patients with sepsis, the science and laboratory investigation of sepsis and the host response to sepsis, and in the design, conduct and interpretation of clinical trials conducted to investigate the treatment of sepsis.

The Sepsis 2018 Symposium will focus on the science and clinical aspects of sepsis including a focus on antibiotic resistance, the management of the patient with sepsis and will include a comprehensive update on ongoing clinical trials and plus presentation of recent trial results.